An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
February 28, 2014
Primary Completion Date
April 30, 2014
Study Completion Date
May 31, 2014
Conditions
Metabolism and Excretion
Interventions
DRUG
E2006
Single oral 10mg dose of 100 uCi \[14C\]E2006
Trial Locations (1)
Unknown
Covance Clinical Research Unit, Madison
All Listed Sponsors
lead
Eisai Inc.
INDUSTRY
NCT02046213 - An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter